Personalis, Inc. reported $70M of revenue over the trailing twelve months, −13% on the year before. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $70M (to Q2 2026). Net income: −$107M, trailing twelve months to Q2 2026. Free cash flow: −$101M, trailing twelve months to Q2 2026. Operating margin: −166%, trailing twelve months to Q2 2026.

PSNLPersonalis, Inc.

Healthcare

$16.00+162% 1Y

$16.00

$5.0452 weeks$18.41

PSNL as reported

Personalis, Inc. reported $70M of revenue over the trailing twelve months, −13% on the year before. 9 reported series are charted on this page, each one as filed.

$70M

Revenue, trailing twelve months · to Q2 2026 · −13% against the twelve months before

Net income: −$107M
Net income · +17% year on year · trailing twelve months to Q2 2026
Free cash flow: −$101M
Free cash flow · +105% year on year · trailing twelve months to Q2 2026
Operating margin: −166%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for PSNL, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$70M	−13%	Q2 2026
Net income	−$107M	+17%	Q2 2026
EPS	−$1.09	−11%	Q2 2026
Gross margin	12%	n/a	Q2 2026
Operating margin	−166%	n/a	Q2 2026
Net margin	−156%	n/a	Q2 2026
ROE	−39%	n/a	Q2 2026
ROA	−30%	n/a	Q2 2026
Free cash flow	−$101M	+105%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.